Protective effects of exerkine on cardiovascular system.
10.11817/j.issn.1672-7347.2025.240698
- Author:
Huiling CHEN
1
,
2
,
3
;
Peizhen ZHANG
1
,
4
Author Information
1. School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing
2. lll100216@
3. com.
4. zhpzh17@hotmail.com.
- Publication Type:Review
- Keywords:
brain-derived neurotrophic factor;
cardiovascular;
exerkine;
exosomal miRNA;
fibroblast growth factor 21;
meteorin-like protein
- MeSH:
Humans;
Cardiovascular Diseases/prevention & control*;
Exercise/physiology*;
Fibroblast Growth Factors/physiology*;
MicroRNAs/metabolism*;
Brain-Derived Neurotrophic Factor/physiology*;
Cardiovascular System/physiopathology*;
Exosomes/metabolism*;
Signal Transduction
- From:
Journal of Central South University(Medical Sciences)
2025;50(4):714-723
- CountryChina
- Language:English
-
Abstract:
Cardiovascular disease (CVD) poses a serious threat to human health. Exercise plays an important role in both the prevention and treatment of CVD and is one of the key non-pharmacological interventions. Exercise can regulate the level of exerkine secreted by different tissue cells, directly affect the cardiovascular system or play a role in cardiovascular protection by improving cardiovascular risk factors. Exerkine such as meteorin-like protein (Metrnl), brain-derived neurotrophic factor (BDNF), fibroblast growth factor 21 (FGF21), and exosomal microRNA (miRNA) play an important role in regulating vascular and cardiac diseases such as atherosclerosis, heart failure, cardiac ischemia-reperfusion and myocardial infarction, as well as their risk factors. Exploring the signaling pathways and mechanisms by which Metrnl, BDNF, FGF21, and exosomal miRNAs exert cardiovascular protective effects can provide novel insights into exercise-based strategies for preventing and treating cardiovascular diseases.
